Direct Comparison of the Efficacy and Safety of Vonoprazan Versus Proton-Pump Inhibitors for Gastroesophageal Reflux Disease: A Systematic Review and Meta-Analysis
GastroenterologiaSobre o estudo
- Desenho
- Metanálise
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- Digestive diseases and sciences
- Publicado em
- 24 fev 2020
- Citações
- 0
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Direct Comparison of the Efficacy and Safety of Vonoprazan Versus Proton-Pump Inhibitors for Gastroesophageal Reflux Disease: A Systematic Review and Meta-Analysis
Yuan Cheng, Jiali Liu, Xiang Tan, Yi Dai, Chune Xie, Xiaohong Li, Qiongqiong Lu, Fushun Kou, Hui Jiang, Junxiang Li
Descritores MeSH
- Proton Pump Inhibitors
- Pyrroles
- Sulfonamides
- Gastroesophageal Reflux
- Treatment Outcome
- Heartburn
- Humans
- Randomized Controlled Trials as Topic
Veja também
Estudos relacionados
- Randomised clinical trial: Efficacy and safety of on-demand vonoprazan versus placebo for non-erosive reflux disease
- A Meta-analysis of PPIs Plus Alginate Versus PPIs Alone for the Treatment of GERD
- Network Meta-analysis Comparing Vonoprazan and Proton Pump Inhibitors for Heartburn Symptoms in Erosive Esophagitis
- Vonoprazan Improves Nocturnal Gastroesophageal Reflux Symptoms in Nonerosive Reflux Disease
- Potassium-competitive acid blockers and proton-pump inhibitors for the healing and maintenance of erosive esophagitis: a comprehensive and updated systematic review with network meta-analysis